Michael Zinda, EVP, Chief Science Officer at Repare Therapeutics Inc. (RPTX), sold 29,268 shares at $33.07 ($958K) on 2021-05-17, disclosed to the SEC on 2021-05-18.
Open-market sale of $958k RPTX by EVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.65 | 732 | $23K | 2.4% |
| 2 | $32.72 | 12,439 | $407K | 42.5% |
| 3 | $32.72 | 12,439 | $407K | 42.5% |
| 4 | $33.07 | 1,829 | $60K | 6.3% |
| 5 | $33.07 | 1,829 | $60K | 6.3% |
| Total | $32.74 avg | 29,268 |
| $958K |
| 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |